Michael Higgins
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
24
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNS Marinus Pharmaceuticals | Downgrades: Neutral | n/a | $0.33 | - | 2 | Aug 14, 2024 | |
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $22.84 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $4.37 | +1,473.23% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.18 | +493.22% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $1.32 | +1,036.36% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $60 | $1.14 | +5,163.62% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $52.99 | -33.95% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $1.19 | +4,101.68% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $130 → $80 | $0.73 | +10,881.47% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $9.12 | +1,051.32% | 2 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $29 | $31.39 | -7.61% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $3.70 | - | 1 | Sep 27, 2017 |
Marinus Pharmaceuticals
Aug 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.33
Upside: -
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $22.84
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $4.37
Upside: +1,473.23%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.18
Upside: +493.22%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.32
Upside: +1,036.36%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $60
Current: $1.14
Upside: +5,163.62%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $52.99
Upside: -33.95%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $1.19
Upside: +4,101.68%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130 → $80
Current: $0.73
Upside: +10,881.47%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $9.12
Upside: +1,051.32%
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $31.39
Upside: -7.61%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $3.70
Upside: -